Abstract

Chronic stress can impair hippocampal neurogenesis, increase neuronal apoptosis, and cause depressive-like behaviors. Our previous studies found that Radix Scutellariae (RS) can rescue the stress-induced neuronal injury, but the mechanism is not clear. Here, we continued to investigate the underlying antidepressant mechanisms of the RS extract. A 7-week chronic unpredictable mild stress (CUMS) procedure was used to establish a murine depression model. 0.75 g/kg or 1.5 g/kg RS was administered daily to the mice during the last 4 weeks. Depressive-like behaviors were evaluated by the sucrose preference test (SPT), forced swimming test (FST), open field test (OFT), and tail suspension test (TST). The neuroprotective effect of RS was evaluated with the expression of hippocampal neuron-related markers and apoptosis-associated proteins by Nissl staining, immunohistochemistry, and western blot. Transforming growth factor-β3 (TGFβ3) pathway-related proteins were detected by western blot. Results showed that RS could ameliorate depressive-like behaviors, increase the expression of the antiapoptotic protein B-cell lymphoma 2 (BCL-2), reduce the expression of the proapoptotic protein BCL-2-associated X (BAX), and increase the number of doublecortin- (DCX-), microtubule-associated protein 2- (MAP2-), and neuronal nucleus- (NeuN-) positive cells in the hippocampus. Moreover, RS could reverse the CUMS-induced decrease of TGFβ3 protein, promote the phosphorylation of SMAD2/3, and increase the expression of downstream NEDD9 protein. These results suggest that RS could exert antidepressant effects via protecting neurons. And the molecular mechanism might be related to the regulation of the TGFβ3-SMAD2/3-NEDD9 pathway.

Highlights

  • Major depressive disorder (MDD) is an affective disorder with a high risk of morbidity and mortality

  • We provided evidence that Radix Scutellariae (RS) treatment modulates neuroprotection in the hippocampus of mice that had undergone the chronic unpredictable mild stress (CUMS) procedure and we identified the Transforming growth factor-β3 (TGFβ3)-SMAD2/3-NEDD9 signaling pathway as a potential molecular mechanism

  • Consistent with previous study [18], our results suggest that mice exposed to CUMS can display depressive-like behavioral deficits, including anhedonia and desperate behaviors

Read more

Summary

Introduction

Major depressive disorder (MDD) is an affective disorder with a high risk of morbidity and mortality. Depression produces the greatest decrement in health compared with the chronic diseases angina, arthritis, asthma, and diabetes [1], making it one of the most prevalent health-related causes of human suffering [2]. The mechanism of depression are far from clear, the most widely accepted theory about the mechanism of depression points to the monoamine neurotransmitters, and the first line of treatment of depression is the monoamine reuptake inhibitors [3]. Even though there are many achievements in pharmacological and psychological therapies, an estimated 44% of patients do not respond to two consecutive antidepressant therapies and an estimated 33% do not respond to four consecutive antidepressant therapies [4]. It is necessary to look for safe and effective drugs to treat MDD

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call